Viemed Healthcare, Inc. $VMD Shares Newly Bought by Bank of America Corp DE

Key Points

• Bank of America bought 158,762 Viemed Healthcare shares in the second quarter, valued at approximately $1.81 million, giving it a 0.42% stake. Institutional investors collectively own 74.24% of the company.
• Viemed reported quarterly revenue of $78.1 million, roughly in line with estimates, but earnings of $0.07 per share missed the $0.12 consensus forecast. The stock opened at $9.08, below its 50-day and 200-day moving averages.
• Analyst sentiment is mixed, with one Buy rating and three Holds; the consensus rating is Hold with an average price target of $14.00.

Bank of America Corp DE bought a new stake in shares of Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 158,762 shares of the company's stock, valued at approximately $1,810,000. Bank of America Corp DE owned approximately 0.42% of Viemed Healthcare as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the business. BlackRock Inc. bought a new stake in shares of Viemed Healthcare in the 2nd quarter worth approximately $54,587,000. Raffles Associates LP bought a new position in shares of Viemed Healthcare during the second quarter valued at $4,602,000. Arrowstreet Capital Limited Partnership increased its holdings in shares of Viemed Healthcare by 101.9% during the first quarter. Arrowstreet Capital Limited Partnership now owns 711,186 shares of the company's stock valued at $6,550,000 after acquiring an additional 358,863 shares in the last quarter. Tocqueville Asset Management L.P. purchased a new position in shares of Viemed Healthcare in the 2nd quarter worth about $3,900,000. Finally, Martin & Co. Inc. TN purchased a new position in shares of Viemed Healthcare in the 2nd quarter worth about $3,885,000. 74.24% of the stock is currently owned by hedge funds and other institutional investors.

Viemed Healthcare Trading Down 0.2%

Viemed Healthcare stock opened at $9.08 on Friday. Viemed Healthcare, Inc. has a one year low of $6.05 and a one year high of $12.61. The business's fifty day moving average is $9.43 and its 200 day moving average is $9.94. The stock has a market capitalization of $345.86 million, a PE ratio of 25.22, a price-to-earnings-growth ratio of 2.25 and a beta of 1.04. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.13 and a quick ratio of 1.02.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last posted its earnings results on Monday, August 3rd. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.05). Viemed Healthcare had a net margin of 4.81% and a return on equity of 10.16%. The company had revenue of $78.10 million for the quarter, compared to the consensus estimate of $78.00 million. On average, sell-side analysts predict that Viemed Healthcare, Inc. will post 0.41 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts recently commented on VMD shares. Weiss Ratings downgraded shares of Viemed Healthcare from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Monday, August 17th. Barrington Research began coverage on shares of Viemed Healthcare in a report on Monday, August 24th. They issued an "outperform" rating and a $14.00 target price for the company. Freedom Capital downgraded shares of Viemed Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, August 5th. Finally, Wall Street Zen downgraded shares of Viemed Healthcare from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 15th. One investment analyst has rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $14.00.

About Viemed Healthcare

Viemed Healthcare, Inc NASDAQ: VMD is a healthcare services company that provides in-home medical equipment and clinical support for patients with chronic respiratory and other complex medical conditions. Its services are designed to help patients receive care at home, reduce avoidable hospitalizations and support ongoing disease management.

The company's offerings include non-invasive ventilation, oxygen therapy, sleep-apnea treatment and related respiratory equipment. Viemed also provides clinical services such as respiratory therapy, patient education, remote monitoring and other home-based care programs.

Want to see what other hedge funds are holding VMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.